Induction of supra-ventricular arrhythmias dobutamine vs isoprotrenole

Phase 3

• Conditions: Cardiac arrhythmia, unspecified.; Cardiac arrhythmia, unspecified; I49.9

• Registration Number: IRCT20230918059453N1
• Lead Sponsor: Shiraz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 13 November 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 500

Inclusion Criteria

All patients underwent ablation

Exclusion Criteria

All patients are included in the study and there are no conditions for non-entry.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Recurrence arrhythmia. Timepoint: 1, 3, and 6 months after the intervention. Method of measurement: Based on recurrence of arrhythmia and need to anti arrhythmic drug or ablation.

Secondary Outcome Measures

Name	Time	Method
Recurrence of chest pain and arrhythmia. Timepoint: 1,3,6 mount. Method of measurement: underwent ECG by cardiologist.